Tepnel Pharma Services uses Hologic’s Invader Plus technology to offer genotyping, CNV service

Tepnel Pharma Services, a division of Hologic, Inc. (Hologic or the Company), is now using Hologic’s proprietary Invader and Invader Plus technology as part of its Molecular Genetic Services offering, enabling it to offer customers a more cost effective and high throughput genotyping and copy number variation (CNV) service.

The Invader chemistry platform is a cost effective isothermal, DNA-probe based system utilised in disease detection, genotyping and CNV assays in a wide range of applications in Agricultural, BioPharma and Academic markets. Invader Plus couples the sensitivity of target amplification with the specificity of Invader chemistry. Its superior accuracy and specificity together with its scalability and low cost position it to outperform competing technologies as a high throughput solution. Invader chemistry is currently used in multiple FDA approved and CE marked products and is used extensively by laboratories worldwide for their clinical diagnostic, research and high throughput genotyping needs.

Dr. Bob Holt, Molecular Genetic Services Manager, Tepnel Pharma Services said “We are excited to offer Invader as part of our Molecular Genetic Service portfolio. The highly versatile nature of the technology will allow Tepnel to expand into the AgBio space and extend our capabilities in biomarker discovery, clinical assay development, and companion diagnostic development in support of pre-clinical, clinical and personalized medicine studies.”

Dr. Michael Kaiser, Hologic’s Director, AgBio & Molecular Research Applications said “Invader chemistry is used in both small and large laboratories around the world. It has a proven track record of meeting customers’ needs for scale, cost and reliability. With the expansion of our IP portfolio provided by the recent Gen-Probe acquisition, we will continue to innovate to meet our customers changing and growing needs.